We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+1.06%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$355M
AUM Growth
-$58.3M
Cap. Flow
-$51.7M
Cap. Flow %
-14.57%
Top 10 Hldgs %
19.68%
Holding
1,105
New
222
Increased
181
Reduced
330
Closed
90

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$24.9M
2
RACE icon
Ferrari
RACE
+$19.1M
3
CNH
CNH Industrial
CNH
+$12.3M
4
IVE icon
iShares S&P 500 Value ETF
IVE
+$8.23M
5
UBS icon
UBS Group
UBS
+$5.09M

Sector Composition

Rank Sector Weight
1 Technology 16.03%
2 Consumer Discretionary 9.4%
3 Healthcare 9.16%
4 Industrials 8.21%
5 Financials 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASML icon
26
ASML
ASML
$596B
$2.27M 0.64%
3,401
-34
-1% -$22.8K
COST icon
27
Costco
COST
$432B
$2.25M 0.63%
3,905
+300
+8% +$157K
ZTS icon
28
Zoetis
ZTS
$32.7B
$2.21M 0.62%
+11,701
New +$2.31M
MCD icon
29
McDonald's
MCD
$193B
$2.19M 0.62%
8,867
-949
-10% -$236K
C icon
30
Citigroup
C
$213B
$2.15M 0.61%
40,273
-3,459
-8% -$214K
FCX icon
31
Freeport-McMoran
FCX
$86.2B
$2.08M 0.59%
41,858
-38,726
-48% -$1.72M
WFC icon
32
Wells Fargo
WFC
$254B
$2.08M 0.59%
+42,872
New +$2.29M
BSX icon
33
Boston Scientific
BSX
$68.4B
$2.03M 0.57%
45,926
-3,459
-7% -$150K
OC icon
34
Owens Corning
OC
$11B
$2.03M 0.57%
22,175
+6,170
+39% +$567K
TSLA icon
35
Tesla
TSLA
$1.18T
$2.01M 0.57%
+5,610
New +$1.75M
JPM icon
36
JPMorgan Chase
JPM
$916B
$1.96M 0.55%
14,379
-6,739
-32% -$995K
CRM icon
37
Salesforce
CRM
$154B
$1.96M 0.55%
9,227
+1,921
+26% +$413K
GLD icon
38
SPDR Gold Trust
GLD
$131B
$1.86M 0.52%
10,277
-2,471
-19% -$434K
UUUU icon
39
Energy Fuels
UUUU
$2.68B
$1.83M 0.52%
199,228
-65,434
-25% -$510K
DNN icon
40
Denison Mines
DNN
$2.43B
$1.82M 0.51%
1,114,929
-281,780
-20% -$398K
IHI icon
41
iShares US Medical Devices ETF
IHI
$3.17B
$1.8M 0.51%
29,501
-1,124
-4% -$67K
AVGO icon
42
Broadcom
AVGO
$1.76T
$1.77M 0.5%
28,110
-5,510
-16% -$327K
XOP icon
43
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.54B
$1.7M 0.48%
+12,635
New +$1.45M
CRBN icon
44
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.12B
$1.6M 0.45%
9,813
-327
-3% -$53.4K
META icon
45
Meta Platforms (Facebook)
META
$1.49T
$1.58M 0.44%
7,097
+759
+12% +$190K
SLB icon
46
SLB Ltd
SLB
$72.7B
$1.52M 0.43%
36,738
+19,403
+112% +$761K
BRK.B icon
47
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.49M 0.42%
4,216
-1,200
-22% -$388K
JNPR
48
DELISTED
Juniper Networks
JNPR
$1.49M 0.42%
40,007
+4,137
+12% +$142K
DOW icon
49
Dow Inc
DOW
$22B
$1.48M 0.42%
23,301
+21,993
+1,681% +$1.33M
AMD icon
50
Advanced Micro Devices
AMD
$700B
$1.48M 0.42%
13,569
+364
+3% +$43.5K

Similar funds

Exane Derivatives's Q1 2022 Portfolio in Review

As of Q1 2022, Exane Derivatives held 1,105 positions worth $355M, down 14% from $413M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Exane Derivatives withdrew a net $51.7M in Q1 2022, closing 90 positions and reducing 330 holdings. Its most notable exit was iShares S&P 500 Value ETF, an estimated $8.23M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Exane Derivatives opened a new position in Visa worth $4.62M.

  • Exane Derivatives's largest Q1 2022 buy was Visa: 20,811 shares worth $4.62M.
  • Exane Derivatives added most to iShares MSCI China ETF in Q1 2022, an estimated $5.54M increase.
  • Exane Derivatives's biggest Q1 2022 reduction was Stellantis, cutting an estimated $24.9M.
  • Exane Derivatives fully exited iShares S&P 500 Value ETF in Q1 2022, selling an estimated $8.23M.
  • Exane Derivatives's ten largest holdings make up 20% of its $355M portfolio in Q1 2022.
  • Exane Derivatives opened 222 new positions and closed 90 in Q1 2022.
  • Exane Derivatives's portfolio value fell 14% quarter-over-quarter to $355M.

Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.